PFG Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712K | Sell |
3,252
-9
| -0.3% | -$1.97K | 0.03% | 354 |
|
|
2025
Q1 | $730K | Buy |
3,261
+1
| +0% | +$224 | 0.04% | 389 |
|
|
2024
Q4 | $1.07M | Sell |
3,260
-351
| -10% | -$115K | 0.07% | 291 |
|
|
2024
Q3 | $1.08M | Buy |
3,611
+6
| +0.2% | +$1.8K | 0.07% | 287 |
|
|
2024
Q2 | $1.19M | Sell |
3,605
-20
| -0.6% | -$6.59K | 0.08% | 262 |
|
|
2024
Q1 | $1.43M | Sell |
3,625
-3
| -0.1% | -$1.19K | 0.1% | 221 |
|
|
2023
Q4 | $1.28M | Sell |
3,628
-4
| -0.1% | -$1.41K | 0.1% | 223 |
|
|
2023
Q3 | $1.36M | Sell |
3,632
-1
| -0% | -$375 | 0.12% | 197 |
|
|
2023
Q2 | $1.39M | Buy |
3,633
+6
| +0.2% | +$2.3K | 0.11% | 226 |
|
|
2023
Q1 | $1.26M | Buy |
3,627
+1
| +0% | +$346 | 0.11% | 232 |
|
|
2022
Q4 | $853K | Hold |
3,626
| – | – | 0.08% | 275 |
|
|
2022
Q3 | $892K | Hold |
3,626
| – | – | 0.1% | 242 |
|
|
2022
Q2 | $1.1M | Buy |
3,626
+29
| +0.8% | +$8.77K | 0.12% | 161 |
|
|
2022
Q1 | $1.48M | Hold |
3,597
| – | – | 0.15% | 147 |
|
|
2021
Q4 | $1.69M | Buy |
3,597
+2,579
| +253% | +$1.21M | 0.17% | 177 |
|
|
2021
Q3 | $432K | Buy |
1,018
+400
| +65% | +$170K | 0.05% | 354 |
|
|
2021
Q2 | $222K | Buy |
+618
| New | +$222K | 0.03% | 447 |
|
|
2021
Q1 | – | Sell |
-771
| Closed | -$218K | – | 463 |
|
|
2020
Q4 | $218K | Buy |
771
+81
| +12% | +$22.9K | 0.04% | 346 |
|
|
2020
Q3 | $202K | Buy |
+690
| New | +$202K | 0.04% | 341 |
|